Drugs by condition
Drugs approved for restless legs syndrome
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
2
Still marketed, NDA or BLA
Drug classes
2
Novel drugs
2
New molecular entities and new biologics
In development
0
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for restless legs syndrome.
All approved drugs for restless legs syndrome, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 14 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Drugs in development for restless legs syndrome
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials list this condition.
More on restless legs syndrome: recruiting trials · published research
Related in neurology: Alzheimer's disease · Parkinson's disease · Multiple sclerosis · Epilepsy and seizures · Migraine · ALS (amyotrophic lateral sclerosis) · Myasthenia gravis · Spinal muscular atrophy · Duchenne muscular dystrophy · Huntington's disease chorea
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.